FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Gregory Merrick

Research Profile

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Anatomy

Co-author Network

Publications

TOP 3
Mark Shilkrut; Matthew H Stenmark; Sean M Vance; Eyad Abu-Isa; Felix Y Feng; Patrick W McLaughlin; Gregory S Merrick; Howard M Sandler; Daniel A Hamstra
The addition of low-dose-rate brachytherapy and androgen-deprivation therapy decreases biochemical failure and prostate cancer death compared with dose-escalated external-beam radiation therapy for high-risk prostate cancer.
Madhu B Shetti; Ashley Torlone; Edward Adamovich; Wayne M Butler; Robert W Galbreath; Jonathan H Lief; Gregory S Merrick; Kent E Wallner
The impact of diabetes mellitus on survival in men with clinically localized prostate cancer treated with permanent interstitial brachytherapy.
Wayne M Butler; Brian Kurko; Gregory S Merrick; Mallory N Morris; Brian C Murray
Effect of body mass index on intrafraction prostate displacement monitored by real-time electromagnetic tracking.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Gregory Merrick (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Mark Shilkrut; Matthew H Stenmark; Sean M Vance; Eyad Abu-Isa; Felix Y Feng; Patrick W McLaughlin; Gregory S Merrick; Howard M Sandler; Daniel A Hamstra
The addition of low-dose-rate brachytherapy and androgen-deprivation therapy decreases biochemical failure and prostate cancer death compared with dose-escalated external-beam radiation therapy for high-risk prostate cancer.
Cancer 2013;119(3):681-90.
2012: Madhu B Shetti; Ashley Torlone; Edward Adamovich; Wayne M Butler; Robert W Galbreath; Jonathan H Lief; Gregory S Merrick; Kent E Wallner
The impact of diabetes mellitus on survival in men with clinically localized prostate cancer treated with permanent interstitial brachytherapy.
American journal of clinical oncology 2012;35(6):572-9.
2012: Wayne M Butler; Brian Kurko; Gregory S Merrick; Mallory N Morris; Brian C Murray
Effect of body mass index on intrafraction prostate displacement monitored by real-time electromagnetic tracking.
International journal of radiation oncology, biology, physics 2012;84(2):e173-9.
2012: Gregory S Merrick; Peter Orio; Al V Taira; Kent E Wallner; Wayne M Butler; Robert W Galbreath; Edward Adamovich
20 Gy versus 44 Gy of supplemental external beam radiotherapy with palladium-103 for patients with greater risk disease: results of a prospective randomized trial.
International journal of radiation oncology, biology, physics 2012;82(3):e449-55.
2011: Gregory S Merrick; John Sylvester; Wayne M Butler; Peter Grimm; Jonathan H Lief; Zachariah A Allen
The effect of pro-qura case volume on post-implant prostate dosimetry.
International journal of radiation oncology, biology, physics 2011;81(5):e727-34.
2011: Gregory S Merrick
American college of radiology appropriateness criteria.
American journal of clinical oncology 2011;34(1):1.
2011: Gregory S Merrick; Wayne M Butler; Robert W Galbreath; Jonathan H Lief; Nathan Bittner; Kent E Wallner; Edward Adamovich
Prostate cancer death is unlikely in high-risk patients following quality permanent interstitial brachytherapy.
BJU international 2011;107(2):226-32.
2011: Gregory S Merrick; John Sylvester; Peter D Grimm; Zachariah A Allen; Wayne M Butler; Joshua L Reed; Jonathan Khanjian
Postimplant rectal dosimetry is not dependent on 103Pd or 125I seed activity.
Brachytherapy 2011;10(1):35-43.
2011: Wayne M Butler; Renee R Stewart; Gregory S Merrick
Evaluation of radiobiologic biochemical control in a large permanent prostate brachytherapy population from a single institution using AAPM TG-137 parameters.
Brachytherapy 2011;10(1):16-28.
2010: L Christine Fang; Gregory S Merrick; Kent E Wallner
Androgen deprivation therapy: a survival benefit or detriment in men with high-risk prostate cancer?
Oncology (Williston Park, N.Y.) 2010;24(9):790-6, 798.
2009: Lydia Everly; Gregory S Merrick; Zachariah A Allen; Wayne M Butler; Kent Wallner; Jonathan H Lief; Robert W Galbreath; Edward Adamovich
Prostate cancer control and survival in Vietnam veterans exposed to Agent Orange.
Brachytherapy 2009;8(1):57-62.
2008: Gregory S Merrick; Kent E Wallner; Robert W Galbreath; Wayne M Butler; Sarah G Brammer; Zachariah A Allen; Jonathan H Lief; Edward Adamovich
Biochemical and functional outcomes following brachytherapy with or without supplemental therapies in men < or = 50 years of age with clinically organ-confined prostate cancer.
American journal of clinical oncology 2008;31(6):539-44.
2008: Gregory S Merrick; Kent E Wallner; Robert W Galbreath; Wayne M Butler; Sarah G Brammer; Zachariah A Allen; Edward Adamovich
Prostate brachytherapy in men > or =75 years of age.
International journal of radiation oncology, biology, physics 2008;72(2):415-20.
2008: Gregory S Merrick; Walter Taubenslag; Hugo Andreini; Sarah Brammer; Wayne M Butler; Edward Adamovich; Zachariah A Allen; Richard Anderson; Kent E Wallner
The morbidity of transperineal template-guided prostate mapping biopsy.
BJU international 2008;101(12):1524-9.
2008: Wayne M Butler; Gregory S Merrick
Clinical practice and quality assurance challenges in modern brachytherapy sources and dosimetry.
International journal of radiation oncology, biology, physics 2008;71(1 Suppl):S142-6.
2007: Laurie J Abel; Debra Zeroski; Sarah Brammer; Wayne Butler; Kent E Wallner; Gregory S Merrick
PSA spike after brachytherapy For localized prostate cancer.
Urologic nursing 2007;27(6):507-10, 518; quiz 511.
2007: Gregory S Merrick; Robert W Galbreath; Wayne M Butler; Kent E Wallner; Zachariah A Allen; Edward Adamovich
Obesity is not predictive of overall survival following permanent prostate brachytherapy.
American journal of clinical oncology 2007;30(6):588-96.
2007: Gregory S Merrick; Sarah Gutman; Hugo Andreini; Walter Taubenslag; David L Lindert; Rodney Curtis; Edward Adamovich; Richard Anderson; Zachariah A Allen; Wayne Butler; Kent Wallner
Prostate cancer distribution in patients diagnosed by transperineal template-guided saturation biopsy.
European urology 2007;52(3):715-23.
2007: Chelsea Bostancic; Gregory S Merrick; Wayne M Butler; Kent E Wallner; Zachariah A Allen; Robert W Galbreath; Jonathan H Lief; Sarah E Gutman
Isotope and patient age predict for PSA spikes after permanent prostate brachytherapy.
International journal of radiation oncology, biology, physics 2007;68(5):1431-7.
2007: Gregory S Merrick; Wayne M Butler; Kent E Wallner; Zachariah A Allen; Brian Kurko; Richard L Anderson; Robert Grammer; Robert W Galbreath; Lawrence True; Edward Adamovich
Dosimetry of an extracapsular anulus following permanent prostate brachytherapy.
American journal of clinical oncology 2007;30(3):228-33.
2007: Gregory S Merrick; Wayne M Butler; Kent E Wallner; Robert W Galbreath; Zachariah A Allen; Edward Adamovich; Jonathan H Lief
Androgen deprivation therapy does not impact cause-specific or overall survival in high-risk prostate cancer managed with brachytherapy and supplemental external beam.
International journal of radiation oncology, biology, physics 2007;68(1):34-40.
2007: Mark A Moyad; Gregory S Merrick
Cholesterol, cholesterol-lowering agents/statins, and urologic disease: Part VI--The recent rise and fall of the HDL-boosting drug torceptrapib.
Urologic nursing 2007;27(2):169-73.
2007: Mark A Moyad; Gregory S Merrick
Cholesterol, cholesterol-lowering agents/statins, and urologic disease: Part V--Statins versus aspirin for primary prevention, and the winner is...?
Urologic nursing 2007;27(2):166-8.
2007: Gregory S Merrick; Wayne M Butler; Kent E Wallner; Robert W Galbreath; Zachariah A Allen; Sarah Gutman; Jonathan H Lief
Long-term rectal function after permanent prostate brachytherapy.
Cancer journal (Sudbury, Mass.) 2007;13(2):95-104.
2007: Gregory S Merrick; Peter D Grimm; John Sylvester; John C Blasko; Wayne M Butler; Zachariah A Allen; Usman-Ul-Haq Chaudhry; Anthony Mazza; Mike Sitter
Initial analysis of Pro-Qura: a multi-institutional database of prostate brachytherapy dosimetry.
Brachytherapy 2007;6(1):9-15.
2007: Steven J Frank; Peter D Grimm; John E Sylvester; Gregory S Merrick; Brian J Davis; Anthony L Zietman; Brian J Moran; David C Beyer; Mack Roach; Daniel H Clarke; Richard G Stock; W Robert Lee; Jeff M Michalski; Kent E Wallner; Mark Hurwitz; Louis Potters; Deborah A Kuban; Bradley R Prestidge; Robyn Vera; Shannon Hathaway; John C Blasko
Interstitial implant alone or in combination with external beam radiation therapy for intermediate-risk prostate cancer: a survey of practice patterns in the United States.
Brachytherapy 2007;6(1):2-8.
2006: Sarah Gutman; Gregory S Merrick; Wayne M Butler; Kent E Wallner; Zachariah A Allen; Robert W Galbreath; Edward Adamovich
Temporal relationship between prostate brachytherapy and the diagnosis of colorectal cancer.
International journal of radiation oncology, biology, physics 2006;66(1):48-55.
2006: Mark A Moyad; Gregory S Merrick
Cholesterol, cholesterol-lowering agents/statins, and urologic disease: Part III--A rapid review of FDA-approved cholesterol-lowering agents.
Urologic nursing 2006;26(4):330-2.
2006: Mark A Moyad; Gregory S Merrick; Wayne M Butler; Kent E Wallner; Robert W Galbreath; Earnest G Butler; Zachariah A Allen; Edward Adamovich
Statins, especially atorvastatin, may improve survival following brachytherapy for clinically localized prostate cancer.
Urologic nursing 2006;26(4):298-303.
2006: Gregory S Merrick; Kent E Wallner; Wayne M Butler; Robert W Galbreath; Zachariah A Allen; Edward Adamovich; Lawrence True
Brachytherapy in men aged < or = 54 years with clinically localized prostate cancer.
BJU international 2006;98(2):324-8.
2006: Gregory S Merrick; Wayne M Butler; Kent E Wallner; Robert W Galbreath; Zachariah A Allen; Brian Kurko
Efficacy of neoadjuvant bicalutamide and dutasteride as a cytoreductive regimen before prostate brachytherapy.
Urology 2006;68(1):116-20.
2006: Gregory S Merrick; Wayne M Butler; Kent E Wallner; Robert W Galbreath; Zachariah A Allen; Edward Adamovich
Androgen-deprivation therapy does not impact cause-specific or overall survival after permanent prostate brachytherapy.
International journal of radiation oncology, biology, physics 2006;65(3):669-77.
2006: Mark A Moyad; Gregory S Merrick
Cholesterol, cholesterol lowering agents/statins, and urologic disease: part II--do you know your Framingham Risk Score?
Urologic nursing 2006;26(3):227-9, 203.
2006: Gregory S Merrick; Kent E Wallner; Wayne M Butler; John C Blasko
Permanent prostate brachytherapy: is supplemental external-beam radiation therapy necessary?
Oncology (Williston Park, N.Y.) 2006;20(5):514-22; discussion 522-5.
2006: Mark A Moyad; Gregory S Merrick
Cholesterol, cholesterol lowering agents/statins, and urologic disease: part I - knowing your numbers.
Urologic nursing 2006;26(2):156-9.
2006: Gregory S Merrick; Wayne M Butler; Kent E Wallner; Robert W Galbreath; Richard L Anderson; Zachariah A Allen; Edward Adamovich
Risk factors for the development of prostate brachytherapy related urethral strictures.
The Journal of urology 2006;175(4):1376-80; discussion 1381.
2006: Sarah Gutman; Gregory S Merrick; Wayne M Butler; Kent E Wallner; Zachariah A Allen; Robert W Galbreath; Edward Adamovich
Severity categories of the International Prostate Symptom Score before, and urinary morbidity after, permanent prostate brachytherapy.
BJU international 2006;97(1):62-8.
2006: Angela Niehaus; Gregory S Merrick; Wayne M Butler; Kent E Wallner; Zachariah A Allen; Robert W Galbreath; Edward Adamovich
The influence of isotope and prostate volume on urinary morbidity after prostate brachytherapy.
International journal of radiation oncology, biology, physics 2006;64(1):136-43.
2005: Mark A Moyad; Gregory S Merrick; Wayne M Butler; Kent E Wallner; Robert W Galbreath; Brian Kurko; Edward Adamovich
Statins, especially atorvastatin, may favorably influence clinical presentation and biochemical progression-free survival after brachytherapy for clinically localized prostate cancer.
Urology 2005;66(6):1150-4.
2005: Debra Zeroski; Laurie J Abel; Wayne M Butler; Kent Wallner; Gregory S Merrick
Factors affecting patient selection for prostate brachytherapy: what nurses should know.
Clinical journal of oncology nursing 2005;9(5):553-60.
2005: Robin L Stipetich; Laurie J Abel; Richard L Anderson; Wayne M Butler; Kent E Wallner; Gregory S Merrick
Nursing considerations in brachytherapy-related erectile dysfunction.
Urologic nursing 2005;25(4):249-54; quiz 259.
2005: Zachariah A Allen; Gregory S Merrick; Wayne M Butler; Kent E Wallner; Brian Kurko; Richard L Anderson; Brian C Murray; Robert W Galbreath
Detailed urethral dosimetry in the evaluation of prostate brachytherapy-related urinary morbidity.
International journal of radiation oncology, biology, physics 2005;62(4):981-7.
2005: Gregory S Merrick; Kent E Wallner; Wayne M Butler
Prostate cryotherapy: more questions than answers.
Urology 2005;66(1):9-15.
2005: Gregory S Merrick; Wayne M Butler; Kent E Wallner; Robert W Galbreath; Richard L Anderson; Brian Kurko; Jonathan H Lief; Zachariah A Allen
Erectile function after prostate brachytherapy.
International journal of radiation oncology, biology, physics 2005;62(2):437-47.
2005: Gregory S Merrick; Wayne M Butler; Kent E Wallner; Zachariah A Allen; John L DeFilippo; Edward Adamovich
Enzymatic prostatic acid phosphatase in the clinical staging of patients diagnosed with prostate cancer.
The West Virginia medical journal 2005;101(3):116-9.
2005: Gregory S Merrick; Wayne M Butler; Kent E Wallner; Zachariah A Allen; Robert W Galbreath; Jonathan H Lief
Brachytherapy-related dysuria.
BJU international 2005;95(4):597-602.
2005: Gregory S Merrick; Wayne M Butler; Kent E Wallner; John C Blasko; Jeff Michalski; Jesse Aronowitz; Peter D Grimm; Brian J Moran; Patrick W McLaughlin; Jacqueline Usher; Jonathan H Lief; Zachariah A Allen
Variability of prostate brachytherapy pre-implant dosimetry: a multi-institutional analysis.
Brachytherapy 2005;4(4):241-51.
2005: Mark A Moyad; Gregory S Merrick
Statins and cholesterol lowering after a cancer diagnosis: why not?
Urologic oncology 2005;23(1):49-55.
2005: Gregory S Merrick; Wayne M Butler; Kent E Wallner; Zachariah A Allen; Robert W Galbreath; Jonathan H Lief; Daniel J Reed
The impact of radiation dose to the urethra on brachytherapy-related dysuria.
Brachytherapy 2005;4(1):45-50.
2005: Gregory S Merrick; Wayne M Butler; Kent E Wallner; Robert W Galbreath; Zachariah A Allen; Jonathan H Lief; Edward Adamovich
Influence of body mass index on biochemical outcome after permanent prostate brachytherapy.
Urology 2005;65(1):95-100.
2005: Gregory S Merrick; Wayne M Butler; Kent E Wallner; Robert W Galbreath; Jonathan H Lief; Zachariah A Allen; Edward Adamovich
Impact of supplemental external beam radiotherapy and/or androgen deprivation therapy on biochemical outcome after permanent prostate brachytherapy.
International journal of radiation oncology, biology, physics 2005;61(1):32-43.
2004: Gregory S Merrick; Wayne M Butler; Kent E Wallner; Robert W Galbreath; Edward Adamovich
Permanent interstitial brachytherapy for clinically organ-confined high-grade prostate cancer with a pretreatment PSA < 20 ng/mL.
American journal of clinical oncology 2004;27(6):611-5.
2004: Gregory S Merrick; Wayne M Butler; Kent E Wallner; Robert W Galbreath; Edward Adamovich
Permanent interstitial brachytherapy in younger patients with clinically organ-confined prostate cancer.
Urology 2004;64(4):754-9.
2004: Ashley Hinerman-Mulroy; Gregory S Merrick; Wayne M Butler; Kent E Wallner; Zachariah A Allen; Edward Adamovich
Androgen deprivation-induced changes in prostate anatomy predict urinary morbidity after permanent interstitial brachytherapy.
International journal of radiation oncology, biology, physics 2004;59(5):1367-82.
2004: Gregory S Merrick; Wayne M Butler; Kent E Wallner; Zachariah A Allen; Jonathan H Lief; Ashley Hinerman-Mulroy; Robert W Galbreath
The impact of prostate volume and neoadjuvant androgen-deprivation therapy on urinary function following prostate brachytherapy.
Cancer journal (Sudbury, Mass.) 2004;10(3):181-9.
2004: Gregory S Merrick; Kent E Wallner; Wayne M Butler
Patient selection for prostate brachytherapy: more myth than fact.
Oncology (Williston Park, N.Y.) 2004;18(4):445-52; discussion 452, 455-7.
2004: Gregory S Merrick; Wayne M Butler; Kent E Wallner; Robert W Galbreath; Jonathan H Lief; Edward Adamovich
Effect of cigarette smoking on biochemical outcome after permanent prostate brachytherapy.
International journal of radiation oncology, biology, physics 2004;58(4):1056-62.
2004: Joseph G Donzella; Gregory S Merrick; David J Lindert; Hugo J Andreini; Rodney L Curtis; Ignacio H Luna; Zachariah Allen; Wayne M Butler
Epididymitis after transrectal ultrasound-guided needle biopsy of prostate gland.
Urology 2004;63(2):306-8.
2004: Gregory S Merrick; Wayne M Butler; Kent E Wallner; Robert W Galbreath; Zachariah A Allen; Edward Adamovich
Temporal effect of neoadjuvant androgen deprivation therapy on PSA kinetics following permanent prostate brachytherapy with or without supplemental external beam radiation.
Brachytherapy 2004;3(3):141-6.
2004: Gregory S Merrick; Wayne M Butler
Rectal function following permanent prostate brachytherapy.
The West Virginia medical journal 2004;100(1):18-20.
2004: Gregory S Merrick; Wayne M Butler; Kent E Wallner; Brian Murray; Zachariah A Allen; Jonathan H Lief; Robert W Galbreath
The effect of hormonal manipulation on urinary function following permanent prostate brachytherapy.
Brachytherapy 2004;3(1):22-9.
2004: Gregory S Merrick; Wayne M Butler; Kent E Wallner; Robert W Galbreath; Jonathan H Lief; Edward Adamovich
Prognostic significance of percent positive biopsies in clinically organ-confined prostate cancer treated with permanent prostate brachytherapy with or without supplemental external-beam radiation.
Cancer journal (Sudbury, Mass.) 2004;10(1):54-60.
2004: Gregory S Merrick; Wayne M Butler; Kent E Wallner; Robert W Galbreath
Effect of transurethral resection on urinary quality of life after permanent prostate brachytherapy.
International journal of radiation oncology, biology, physics 2004;58(1):81-8.
2004: Gregory S Merrick; Wayne M Butler; Kent E Wallner; Brian C Murray; Zachariah A Allen; Robert W Galbreath
Influence of hormonal therapy on late rectal function after permanent prostate brachytherapy with or without supplemental external beam radiotherapy.
International journal of radiation oncology, biology, physics 2004;58(1):68-74.
2003: Gregory S Merrick; Kent E Wallner; Wayne M Butler
Minimizing prostate brachytherapy-related morbidity.
Urology 2003;62(5):786-92.
2003: Gregory S Merrick; Wayne M Butler; Kent E Wallner; Lauren R Burden; Jackee E Dougherty
Extracapsular radiation dose distribution after permanent prostate brachytherapy.
American journal of clinical oncology 2003;26(5):e178-89.
2003: Gregory S Merrick; Wayne M Butler; Kent E Wallner; Amber L Hines; Zachariah A Allen
Late rectal function after prostate brachytherapy.
International journal of radiation oncology, biology, physics 2003;57(1):42-8.
2003: Gregory S Merrick; Wayne M Butler; Kent E Wallner; Robert W Galbreath; Jonathan H Lief
Long-term urinary quality of life after permanent prostate brachytherapy.
International journal of radiation oncology, biology, physics 2003;56(2):454-61.
2003: Gregory S Merrick; Kent E Wallner; Wayne M Butler
Permanent interstitial brachytherapy for the management of carcinoma of the prostate gland.
The Journal of urology 2003;169(5):1643-52.
2003: Gregory S Merrick; Wayne M Butler; Kent E Wallner; Robert W Galbreath; Brian Murray; Debra Zeroski; Jonathan H Lief
Dysuria after permanent prostate brachytherapy.
International journal of radiation oncology, biology, physics 2003;55(4):979-85.
2003: Gregory S Merrick
The role of hormonal therapy in prostate brachytherapy. Counterpoint.
Brachytherapy 2003;2(1):2-4.
2003: Gregory S Merrick; Wayne M Butler; Kent E Wallner; Jonathan H Lief; Ashley Hinerman-Mulroy; Robert W Galbreath
Prostate-specific antigen (PSA) velocity and benign prostate hypertrophy predict for PSA spikes following prostate brachytherapy.
Brachytherapy 2003;2(3):181-8.
2003: Gregory S Merrick; Wayne M Butler; Kent E Wallner; Robert W Galbreath; Brian Kurko; Sabrina Cleavinger
Rectal function following brachytherapy with or without supplemental external beam radiation: results of two prospective randomized trials.
Brachytherapy 2003;2(3):147-57.
2003: Gregory S Merrick; Wayne M Butler
The dosimetry of brachytherapy-induced erectile dysfunction.
Medical dosimetry : official journal of the American Association of Medical Dosimetrists 2003;28(4):271-4.
2003: Wayne M Butler; Gregory S Merrick
Myths and fallacies in permanent prostate brachytherapy.
Medical dosimetry : official journal of the American Association of Medical Dosimetrists 2003;28(3):155-65.
2003: Laurie J Abel; Jane Dafoe-Lambie; Wayne M Butler; Gregory S Merrick
Treatment outcomes and quality-of-life issues for patients treated with prostate brachytherapy.
Clinical journal of oncology nursing 2003;7(1):48-54.
2003: Gregory S Merrick; Wayne M Butler; Robert W Galbreath; Jonathan H Lief; Edward Adamovich
Does hormonal manipulation in conjunction with permanent interstitial brachytherapy, with or without supplemental external beam irradiation, improve the biochemical outcome for men with intermediate or high-risk prostate cancer?
BJU international 2003;91(1):23-9.
2002: Gregory S Merrick; Wayne M Butler; Kent E Wallner; Jonathan H Lief; Richard L Anderson; Benjamin J Smeiles; Robert W Galbreath; Mark L Benson
The importance of radiation doses to the penile bulb vs. crura in the development of postbrachytherapy erectile dysfunction.
International journal of radiation oncology, biology, physics 2002;54(4):1055-62.
2002: Gregory S Merrick; Wayne M Butler; Kent E Wallner; Jonathan H Lief; Robert W Galbreath
Prophylactic versus therapeutic alpha-blockers after permanent prostate brachytherapy.
Urology 2002;60(4):650-5.
2002: Gregory S Merrick; Wayne M Butler; Kent E Wallner; Robert W Galbreath; Richard L Anderson
Prostate-specific antigen spikes after permanent prostate brachytherapy.
International journal of radiation oncology, biology, physics 2002;54(2):450-6.
2002: Robin L Stipetich; Laurie J Abel; Heather J Blatt; Robert W Galbreath; Jonathan H Lief; Wayne M Butler; Gregory S Merrick
Nursing assessment of sexual function following permanent prostate brachytherapy for patients with early-stage prostate cancer.
Clinical journal of oncology nursing 2002;6(5):271-4.
2002: Kent E Wallner; Gregory S Merrick; Mark L Benson; Wayne M Butler; Jeffrey Maki; Bryan G Tollenaar
Penile bulb imaging.
International journal of radiation oncology, biology, physics 2002;53(4):928-33.
2002: Gregory S Merrick; Wayne M Butler; Jonathan H Lief; Robert W Galbreath; Edward Adamovich
Biochemical outcome for hormone-naïve patients with high-risk prostate cancer managed with permanent interstitial brachytherapy and supplemental external-beam radiation.
Cancer journal (Sudbury, Mass.) 2002;8(4):322-7.
2002: Gregory S Merrick; Wayne M Butler; Kent Wallner; Robert W Galbreath; Richard L Anderson; Brian Kurko; Jonathan H Lief
Permanent prostate brachytherapy-induced morbidity in patients with grade II and III obesity.
Urology 2002;60(1):104-8.
2002: Gregory S Merrick; Wayne M Butler; Robert W Galbreath; Jonathan H Lief; Edward Adamovich
Biochemical outcome for hormone-naive patients with Gleason score 3+4 versus 4+3 prostate cancer undergoing permanent prostate brachytherapy.
Urology 2002;60(1):98-103.
2002: Gregory S Merrick; Wayne M Butler; Robert W Galbreath; Robin L Stipetich; Laurie J Abel; Jonathan H Lief
Erectile function after permanent prostate brachytherapy.
International journal of radiation oncology, biology, physics 2002;52(4):893-902.
2002: Gregory S Merrick; Wayne M Butler; Robert W Galbreath; Jonathan H Lief; Edward Adamovich
Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland.
International journal of radiation oncology, biology, physics 2002;52(3):664-73.
2002: Gregory S Merrick; Wayne M Butler; Bryan G Tollenaar; Robert W Galbreath; Jonathan H Lief
The dosimetry of prostate brachytherapy-induced urethral strictures.
International journal of radiation oncology, biology, physics 2002;52(2):461-8.
2002: Gregory S Merrick; Wayne M Butler; Jonathan H Lief; Robert W Galbreath; Edward Adamovich
Biochemical outcome for hormone-naïve intermediate-risk prostate cancer managed with permanent interstitial brachytherapy and supplemental external beam radiation.
Brachytherapy 2002;1(2):95-101.
2001: Gregory S Merrick; K Wallner; Wayne M Butler; Jonathan H Lief; S Sutlief
Short-term sexual function after prostate brachytherapy.
International journal of cancer. Journal international du cancer 2001;96(5):313-9.
2001: Heather J Blatt; Laurie J Abel; Robin L Stipetich; Robert W Galbreath; Jonathan H Lief; Wayne M Butler; Gregory S Merrick
Utilization of a self-administered questionnaire to assess rectal function following prostate brachytherapy.
Urologic nursing 2001;21(5):356-9.
2001: Gregory S Merrick; Wayne M Butler; AT Dorsey; Jonathan H Lief
Effect of prostate size and isotope selection on dosimetric quality following permanent seed implantation.
Techniques in urology 2001;7(3):233-40.
2001: Gregory S Merrick; Wayne M Butler; Robert W Galbreath; Jonathan H Lief
Five-year biochemical outcome following permanent interstitial brachytherapy for clinical T1-T3 prostate cancer.
International journal of radiation oncology, biology, physics 2001;51(1):41-8.
2001: Gregory S Merrick; Wayne M Butler; Jonathan H Lief; Robert W Galbreath
Five-year biochemical outcome after prostate brachytherapy for hormone-naive men < or = 62 years of age.
International journal of radiation oncology, biology, physics 2001;50(5):1253-7.
2001: Gregory S Merrick; K Wallner; Wayne M Butler; Robert W Galbreath; Jonathan H Lief; Mark L Benson
A comparison of radiation dose to the bulb of the penis in men with and without prostate brachytherapy-induced erectile dysfunction.
International journal of radiation oncology, biology, physics 2001;50(3):597-604.
2001: Gregory S Merrick; Wayne M Butler; Jonathan H Lief; AT Dorsey
Is brachytherapy comparable with radical prostatectomy and external-beam radiation for clinically localized prostate cancer?
Techniques in urology 2001;7(1):12-9.
2001: Gregory S Merrick; Wayne M Butler; Robert W Galbreath; Jonathan H Lief; Joseph G Donzella
Relationship between the transition zone index of the prostate gland and urinary morbidity after brachytherapy.
Urology 2001;57(3):524-9.
2000: Wayne M Butler; Gregory S Merrick; AT Dorsey; B M Hagedorn
Comparison of dose length, area, and volume histograms as quantifiers of urethral dose in prostate brachytherapy.
International journal of radiation oncology, biology, physics 2000;48(5):1575-82.
2000: Gregory S Merrick; Wayne M Butler; AT Dorsey; Jonathan H Lief; Joseph G Donzella
A comparison of radiation dose to the neurovascular bundles in men with and without prostate brachytherapy-induced erectile dysfunction.
International journal of radiation oncology, biology, physics 2000;48(4):1069-74.
2000: Gregory S Merrick; Wayne M Butler; AT Dorsey; Robert W Galbreath; Heather J Blatt; Jonathan H Lief
Rectal function following prostate brachytherapy.
International journal of radiation oncology, biology, physics 2000;48(3):667-74.
2000: Gregory S Merrick; Wayne M Butler; AT Dorsey; Jonathan H Lief; R J Coram
Influence of prophylactic dexamethasone on edema following prostate brachytherapy.
Techniques in urology 2000;6(2):117-22.
2000: Gregory S Merrick; Wayne M Butler
Modified uniform seed loading for prostate brachytherapy: rationale, design, and evaluation.
Techniques in urology 2000;6(2):78-84.
2000: Laurie J Abel; Heather J Blatt; Robin L Stipetich; JA Fuscardo; Jane Dafoe-Lambie; AT Dorsey; Wayne M Butler; Gregory S Merrick
The role of urinary assessment scores in the nursing management of patients receiving prostate brachytherapy.
Clinical journal of oncology nursing 2000;4(3):126-9.
2000: Wayne M Butler; Gregory S Merrick; AT Dorsey; Jonathan H Lief
Isotope choice and the effect of edema on prostate brachytherapy dosimetry.
Medical physics 2000;27(5):1067-75.
2000: Gregory S Merrick; Wayne M Butler; Jonathan H Lief; AT Dorsey
Temporal resolution of urinary morbidity following prostate brachytherapy.
International journal of radiation oncology, biology, physics 2000;47(1):121-8.
2000: Wayne M Butler; Gregory S Merrick; Jonathan H Lief; AT Dorsey
Comparison of seed loading approaches in prostate brachytherapy.
Medical physics 2000;27(2):381-92.
2000: Gregory S Merrick; Wayne M Butler; AT Dorsey; J T Dorsey
The effect of constipation on rectal dosimetry following prostate brachytherapy.
Medical dosimetry : official journal of the American Association of Medical Dosimetrists 2000;25(4):237-41.
2000: Wayne M Butler; Gregory S Merrick; AT Dorsey; Jonathan H Lief; Robert W Galbreath
Modern prostate brachytherapy.
Medical dosimetry : official journal of the American Association of Medical Dosimetrists 2000;25(3):149-53.
2000: Jane Dafoe-Lambie; Laurie J Abel; Heather J Blatt; JA Fuscardo; Robin L Stipetich; Jonathan H Lief; AT Dorsey; Wayne M Butler; Mark L Benson; Gregory S Merrick
Radioactive seed embolization to the lung following prostate brachytherapy.
The West Virginia medical journal 2000;96(1):357-60.
2000: Gregory S Merrick; Wayne M Butler; AT Dorsey; Jonathan H Lief; Mark L Benson
Seed fixity in the prostate/periprostatic region following brachytherapy.
International journal of radiation oncology, biology, physics 2000;46(1):215-20.
1999: Gregory S Merrick; Wayne M Butler; AT Dorsey; Jonathan H Lief
The dependence of prostate postimplant dosimetric quality on CT volume determination.
International journal of radiation oncology, biology, physics 1999;44(5):1111-7.
1999: Gregory S Merrick; Wayne M Butler; Jonathan H Lief; Robin L Stipetich; Laurie J Abel; AT Dorsey
Efficacy of sildenafil citrate in prostate brachytherapy patients with erectile dysfunction.
Urology 1999;53(6):1112-6.
1999: Gregory S Merrick; Wayne M Butler; AT Dorsey; Jonathan H Lief
Potential role of various dosimetric quality indicators in prostate brachytherapy.
International journal of radiation oncology, biology, physics 1999;44(3):717-24.
1999: Gregory S Merrick; Wayne M Butler; P D Grimm
Prostate-specific antigen levels after radical prostatectomy versus brachytherapy.
Urology 1999;53(4):865-6.
1999: Gregory S Merrick; Wayne M Butler; AT Dorsey; Jonathan H Lief; HL Walbert; Heather J Blatt
Rectal dosimetric analysis following prostate brachytherapy.
International journal of radiation oncology, biology, physics 1999;43(5):1021-7.
1999: W H Farthing; Gregory S Merrick; Wayne M Butler; AT Dorsey; E Adamovich
Needle biopsies of prostate cancer.
The American journal of surgical pathology 1999;23(2):239-40.
1999: Laurie J Abel; Heather J Blatt; Robin L Stipetich; JA Fuscardo; Debra Zeroski; S E Miller; AT Dorsey; Wayne M Butler; Gregory S Merrick
Nursing management of patients receiving brachytherapy for early stage prostate cancer.
Clinical journal of oncology nursing 1999;3(1):7-15.
1998: Wayne M Butler; AT Dorsey; K R Nelson; Gregory S Merrick
Quality assurance calibration of 125I rapid strand in a sterile environment.
International journal of radiation oncology, biology, physics 1998;41(1):217-22.
1998: Gregory S Merrick; Wayne M Butler; AT Dorsey; HL Walbert
Influence of timing on the dosimetric analysis of transperineal ultrasound-guided, prostatic conformal brachytherapy.
Radiation oncology investigations 1998;6(4):182-90.
1997: Gregory S Merrick; Wayne M Butler; AT Dorsey; HL Walbert
Prostatic conformal brachytherapy: 125I/103Pd postoperative dosimetric analysis.
Radiation oncology investigations 1997;5(6):305-13.